Valuation: BOIRON

Market Cap 458M 530M 431M 392M 736M 50.61B 748M 5.05B 1.97B 25.38B 1.99B 1.95B 84.51B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 411M 475M 386M 351M 659M 45.32B 670M 4.52B 1.77B 22.73B 1.78B 1.74B 75.68B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week-3.64%
Current month-2.21%
1 month-2.21%
3 months-7.67%
6 months-10.02%
Current year-11.07%
1 week 26.5
Extreme 26.5
27.5
1 month 26.5
Extreme 26.5
27.5
3 years 20.5
Extreme 20.5
55.9
5 years 20.5
Extreme 20.5
55.9
10 years 20.5
Extreme 20.5
91.9
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.64%+22.12%-48.44% 531M
-0.85%-1.30%-10.66%-8.03% 13.35B
-1.45%-1.41%-32.69%-56.83% 5.05B
-1.44%-3.58%+2.63%+0.58% 4.98B
-0.82%+4.31%+5.02%-30.41% 4.24B
-1.69%-1.90%-15.41%-7.38% 3.65B
-1.96%-9.52%-8.48%-2.27% 3.42B
-0.65%-1.03%-5.95%+15.00% 3.42B
-0.56%+3.11%-14.19%-15.51% 2.5B
+2.56%+13.21%+2.78%-9.09% 1.76B
Average -0.76%-0.85%-5.48%-16.24% 4.71B
Weighted average by Cap. -0.97%-1.82%-9.27%-13.62%

Financials

2024 2025
Net sales 488M 564M 459M 417M 782M 53.83B 796M 5.37B 2.1B 27B 2.12B 2.07B 89.89B 501M 580M 471M 428M 804M 55.32B 818M 5.52B 2.16B 27.75B 2.18B 2.13B 92.39B
Net income 11.34M 13.11M 10.66M 9.69M 18.19M 1.25B 18.51M 125M 48.83M 628M 49.22M 48.15M 2.09B 32.64M 37.75M 30.7M 27.9M 52.39M 3.6B 53.3M 360M 141M 1.81B 142M 139M 6.02B
Net Debt -49.74M -57.52M -46.78M -42.51M -79.82M -5.49B -81.21M -548M -214M -2.75B -216M -211M -9.17B -47.86M -55.34M -45.01M -40.91M -76.8M -5.28B -78.14M -527M -206M -2.65B -208M -203M -8.82B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
26-08-14 €26.50 0.00%
26-08-13 €26.50 0.00%
26-08-12 €26.50 0.00%
26-08-11 €26.50 -0.75%
26-08-10 €26.70 -2.91%

Annual profits - Rate of surprise